Conditional deletion of Krüppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury
about
Kruppel-like factor 15 is critical for vascular inflammationMammalian Krüppel-like factors in health and diseasesMicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injuryThe Role of Krüppel-like Factor 4 in Renal FibrosisRegulation of an inflammatory disease: Krüppel-like factors and atherosclerosisMolecular mechanisms of pulmonary arterial remodelingOrigin and differentiation of vascular smooth muscle cellsMicroRNA-1 regulates smooth muscle cell differentiation by repressing Kruppel-like factor 4HDAC2 phosphorylation-dependent Klf5 deacetylation and RARα acetylation induced by RAR agonist switch the transcription regulatory programs of p21 in VSMCsKruppel-like factor 4, Elk-1, and histone deacetylases cooperatively suppress smooth muscle cell differentiation markers in response to oxidized phospholipids.Activation of the pluripotency factor OCT4 in smooth muscle cells is atheroprotective.Vascular Smooth Muscle Cells in Atherosclerosis.KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis.Recent insights into the cellular biology of atherosclerosisRegulation of vascular smooth muscle phenotype by cross-regulation of krüppel-like factorsC/EBP-Homologous Protein (CHOP) in Vascular Smooth Muscle Cells Regulates Their Proliferation in Aortic Explants and Atherosclerotic LesionsKLF4 regulates abdominal aortic aneurysm morphology and deletion attenuates aneurysm formationCooperative binding of KLF4, pELK-1, and HDAC2 to a G/C repressor element in the SM22α promoter mediates transcriptional silencing during SMC phenotypic switching in vivo.Smooth muscle cell phenotypic switching in atherosclerosisPDGF-dependent regulation of regulator of G protein signaling-5 expression and vascular smooth muscle cell functionality.PIAS1 mediates TGFbeta-induced SM alpha-actin gene expression through inhibition of KLF4 function-expression by protein sumoylationSmooth and cardiac muscle-selective knock-out of Kruppel-like factor 4 causes postnatal death and growth retardation.Cyclosporine up-regulates Krüppel-like factor-4 (KLF4) in vascular smooth muscle cells and drives phenotypic modulation in vivo.Smooth muscle phenotypic modulation is an early event in aortic aneurysmsSp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle.Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration.Vascular smooth muscle cells in cerebral aneurysm pathogenesis.PDGF-mediated autophagy regulates vascular smooth muscle cell phenotype and resistance to oxidative stressUpregulation of Oct-4 isoforms in pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertensionEndothelial Krüppel-like factor 4 modulates pulmonary arterial hypertensionKrüppel-like factor 4 promotes differentiation by transforming growth factor-beta receptor-mediated Smad and p38 MAPK signaling in vascular smooth muscle cellsKrüppel-like factor 4 regulates pressure-induced cardiac hypertrophy.Kruppel-like factor 15 regulates smooth muscle response to vascular injury--brief reportTargeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice.Kruppel-like factor-4 transcriptionally regulates VE-cadherin expression and endothelial barrier functionKrüppel-like factor 4 transcriptionally regulates TGF-β1 and contributes to cardiac myofibroblast differentiation.The Krüppel-like factor 2 and Krüppel-like factor 4 genes interact to maintain endothelial integrity in mouse embryonic vasculogenesis"Go with the flow": how Krüppel-like factor 2 regulates the vasoprotective effects of shear stress.down-regulation of Kruppel-like factor-4 (KLF4) by microRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-beta and bone morphogenetic protein 4Kruppel-like factors in muscle health and disease.
P2860
Q24321728-544A8D3B-5CF2-4B18-83A8-843B66274B0DQ24612560-98B6A094-65E6-4295-81E0-0CACEE839DD1Q24647407-86503CE8-4A34-44D2-92A4-5A62A30D3E18Q26776165-718325DE-DEAE-454A-B47D-C99C84F0AD88Q26852339-3741AE6C-3FB6-4BBD-8218-870453E0FADEQ26991806-942E9485-3245-4F49-AB40-6425C1EDE2E0Q28080750-2CC590B5-A6DB-48E1-92B9-F15F3F2B29E8Q28291928-2E147AA1-64C2-4112-B8FD-630971D87005Q28577473-6647264F-F3AB-4CC1-88C9-4214DE5075F3Q28579612-B4058C81-C52F-4D44-BAB9-B090CE34BF4FQ30276803-7DEBF159-6F1E-4563-9779-A4218258FF12Q30277316-B698D0A2-9ACB-4947-B5FB-354C4C8DA807Q30299921-4D924F89-0CA6-46BC-B9C7-95DB92904B8AQ30300194-FEFE7D2E-7F94-402E-8F7B-AA15DCE45679Q30354532-051927D3-FE3C-44A5-912C-B3FB591A2416Q30359005-6D36A795-5F16-4294-8C6B-4CCAC703C8F0Q30410765-26A46EEE-CD2F-4BA0-911E-A24E7809F525Q30417509-C40FEC3D-D17A-4DB7-95F4-9F39D72DBD18Q30418243-B8A2B427-8408-43C6-910A-ACC0A05A1B07Q30425676-E373A96F-5F60-4475-A2CE-30A3A15380DAQ30427433-638235B1-241C-4367-B22F-8CA360DF6B58Q30431496-EE0C3498-039E-4ECD-89B2-BE36D2E95151Q30432856-0115DAC6-33B9-48BB-84A6-2246708ACD48Q30434473-35E4BBD5-9057-46BA-8006-DA81135EF660Q30436555-102861C1-196B-4A39-9BE2-A8EE09424914Q30436774-007AEE83-AA9A-41C1-9DF6-AE67A7133147Q30457214-FED08D91-3DC7-41DA-B3AB-B0C16E7C661FQ33696216-7A61DE9B-C366-4304-9A6A-53F3655AF476Q33784103-3227811E-824F-453B-A1BA-41FACA35269DQ33799629-90551C9C-8DE3-46E4-A469-126E4B152725Q33885311-CA0D31DA-DE9C-44E8-B4B0-4A19C5736C71Q33912489-DEB7CEA0-5A9D-4C97-8370-D7E785D950AAQ34118203-1C41E589-9E19-4ADC-8A58-8AB45E60682EQ34121996-1BE307DF-3340-49A0-B308-3353F33ACD8AQ34132272-5285D394-8A75-4645-B7BB-733C5BA2DEACQ34707131-4FB8E8F1-EB07-4080-80DA-D7239EB76570Q35049841-9AEAA92B-9C25-4BEC-9782-36301724E8ACQ35130262-177CF6D3-E9AC-4390-96DA-26FF65E48505Q35150101-FC18F5C5-8903-49B5-8B1D-014A51F13065Q35575864-8D63F1CD-E7B6-4E32-848B-F8C2FDCEF205
P2860
Conditional deletion of Krüppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Conditional deletion of Krüppe ...... tion following vascular injury
@ast
Conditional deletion of Krüppe ...... tion following vascular injury
@en
type
label
Conditional deletion of Krüppe ...... tion following vascular injury
@ast
Conditional deletion of Krüppe ...... tion following vascular injury
@en
prefLabel
Conditional deletion of Krüppe ...... tion following vascular injury
@ast
Conditional deletion of Krüppe ...... tion following vascular injury
@en
P2093
P2860
P1433
P1476
Conditional deletion of Krüppe ...... tion following vascular injury
@en
P2093
Gary K Owens
Klaus H Kaestner
Tadashi Yoshida
P2860
P304
P356
10.1161/CIRCRESAHA.108.176974
P577
2008-05-15T00:00:00Z